XML 19 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Revenue:    
Total revenue $ 106,340 $ 97,948
Cost of revenue:    
Total cost of revenue 55,890 60,897
Gross profit 50,450 37,051
Research and development 25,948 37,382
Selling, general and administrative 87,541 102,285
Restructuring and related charges 7,076 9,732
Transaction-related expenses 6,485 3,857
Total operating expenses 127,050 153,256
Loss from operations (76,600) (116,205)
Interest expense (4,567) (4,331)
Loss on forward sale of Series B Preferred Stock 0 (60,081)
Loss on Bridge Loans 0 (13,719)
Other income (expense), net 6,963 1,408
Loss before income taxes (74,204) (192,928)
Income tax benefit (expense) (452) 2,830
Net loss $ (74,656) $ (190,098)
Net loss per share, basic (in dollars per share) $ (0.94) $ (2.43)
Net loss per share, diluted (in dollars per share) $ (0.94) $ (2.43)
Shares used in computing net loss per share, basic (in shares) 79,160 78,305
Shares used in computing net loss per share, diluted (in shares) 79,160 78,305
Service revenue    
Revenue:    
Total revenue $ 25,980 $ 23,712
Product revenue    
Revenue:    
Total revenue 79,198 72,454
Cost of revenue:    
Total cost of revenue 44,942 52,555
Service and other revenue    
Revenue:    
Total revenue 27,142 25,494
Cost of revenue:    
Total cost of revenue 10,948 8,342
Other revenue    
Revenue:    
Total revenue $ 1,162 $ 1,782